Alimera Sciences Inc - ESG Rating & Company Profile powered by AI
The page contains a zero-cost ESG analysis covering Alimera Sciences Inc. This assessment of Alimera Sciences Inc incorporates intelligence from across the internet and also from available disclosures by Alimera Sciences Inc. The webpage contains a questions and answers table on Alimera Sciences Inc.
Alimera Sciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.3; made up of an environmental score of 0.0, social score of 0.0 and governance score of 4.0.
1.3
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1747 | Sinphar Pharmaceutical Co Ltd | 1.4 | Low |
| 1747 | WooGene B&G Co Ltd | 1.4 | Low |
| 1755 | Alimera Sciences Inc | 1.3 | Low |
| 1755 | Cheng Du Sheng Nuo Biotec Co Ltd | 1.3 | Low |
| 1755 | ALX Oncology Holdings Inc | 1.3 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Alimera Sciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Alimera Sciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Alimera Sciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Alimera Sciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Alimera Sciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Alimera Sciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Alimera Sciences Inc offer flexible work?
Sign up for free to unlockDoes Alimera Sciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Alimera Sciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Alimera Sciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Alimera Sciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Alimera Sciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Alimera Sciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Alimera Sciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Alimera Sciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Alimera Sciences Inc disclose water use targets?
Sign up for free to unlockDoes Alimera Sciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Alimera Sciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Alimera Sciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Alimera Sciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Alimera Sciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Alimera Sciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Alimera Sciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Alimera Sciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Alimera Sciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Alimera Sciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Alimera Sciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Alimera Sciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Alimera Sciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Alimera Sciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Alimera Sciences Inc disclose its waste policy?
Sign up for free to unlockDoes Alimera Sciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Alimera Sciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Alimera Sciences Inc disclose energy use targets?
Sign up for free to unlockDoes Alimera Sciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Alimera Sciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Alimera Sciences Inc
These potential risks are based on the size, segment and geographies of the company.
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.